MCADD 2023 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, “International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery” (MCADD 2023) Hybrid event during September 14-16, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at medicinal-chemistry@magnusconference.com or call + 1 (702) 988 2320.
International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery
September 14-16, 2023
Medicinal Companies and Market Analysis
The worldwide medicines industry is predicted to expand at a compound annual growth rate (CAGR) of 1.8 percent from $1228.45 billion in 2020 to $1250.24 billion in 2021. The increase is primarily due to companies reorganising their operations and recovering from the impact of COVID-19, which had previously resulted in restrictive containment measures such as social distancing, remote working, and the closure of commercial activities, all of which created operational challenges. At an annual growth rate of 8%, the market is estimated to reach $1700.97 billion in 2025. The pharmaceuticals market consists of sales of pharmaceuticals and related services by entities that produce pharmaceuticals used to treat diseases (organizations, sole traders, and partnerships). Pharmaceuticals can be any form of medicine that is used to treat disorders for therapeutic purposes. Establishments that generate biologics and pharmaceutical medications are included in this industry. The pharmaceuticals industry is divided into two categories: pharmaceutical medications and biologics.
- Market Trends
- Market Analysis
Submit your abstract Today
Title : A qsar survey on tyrosine kinase inhibitors
Atefeh Hajiagha Bozorgi, Faculty of pharmacy, Iran (Islamic Republic of)
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™
Philip M Hemken, Abbott Laboratories, United States
Title : Synthesis, antibacterial activity of 3-amino 5-methoxyl-2-methyl quinazolin-4(3H)-one an amino-6-methoxyl-2-methyl of 4H–benzo[d] [1,3]–oxazine–4–one
Osarumwense Peter Osarodion, Ondo State University of Sciences and Technology, Nigeria
Title : Tackling mycobacterium tuberculosis resistance with tailored isatin-pyrimidine hybrids enoyl acyl carrier protein reductase (Inha)
Amgad Albohy, The British University in Egypt (BUE), Egypt
Title : Transition metal complexes/Organometallic compounfs as anticancer drugs
Prakash kinthda, Nims university,jaipur,rajasthan, India
Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Ahmed, Kafrelsheikh University, Egypt